Loading clinical trials...
Loading clinical trials...
The purpose of this study is to evaluate the drug levels of mezigdomide in participants with renal impairment.
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Celgene
NCT07154901 · Renal Impairment
NCT07165015 · Renal Impairment, Healthy, and more
NCT06693765 · Renal Impairment, End-stage Kidney Disease, and more
NCT06352411 · Healthy, Renal Impairment
NCT06835127 · Renal Impairment, Limb Ischemia, Critical
PANAX
Miami Lakes, Florida
Omega Research Group - Orlando
Orlando, Florida
Orlando Clinical Research Center OCRC
Orlando, Florida
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions